SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-06-19 20:54
Tx date 2024-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$2,536
+486 vol
$5.22 each
154,835
Filed 2024-06-19 20:54
Tx date 2024-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$12,373
+2,137 vol
$5.79 each
154,349
Filed 2024-06-13 15:08
Tx date 2024-06-10
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-116,022
-20,000 vol
$5.80 each
152,212
Filed 2024-06-13 15:08
Tx date 2024-06-10
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$104,000
+20,000 vol
$5.20 each
172,212
Filed 2024-06-13 15:06
Tx date 2024-06-10
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-104,000
-20,000 vol
$5.20 each
724,952
Filed 2024-04-25 14:05
Tx date 2024-04-12
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$715,000
+125,000 vol
$5.72 each
744,952
Filed 2024-04-25 14:05
Tx date 2024-04-12
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$715,000
+125,000 vol
$5.72 each
619,952
Filed 2024-04-25 14:04
Tx date 2024-04-12
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$901,809
+157,659 vol
$5.72 each
494,952
Filed 2024-04-16 18:19
Tx date 2024-04-12
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$712,500
+125,000 vol
$5.70 each
Filed 2024-04-16 18:19
Tx date 2024-04-12
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$712,500
+125,000 vol
$5.70 each
Filed 2024-04-16 18:18
Tx date 2024-04-12
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$894,854
+156,992 vol
$5.70 each
Filed 2024-04-16 18:21
Tx date 2024-04-12
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$308,626
+54,145 vol
$5.70 each
95,923
Filed 2024-04-16 18:19
Tx date 2024-04-12
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$712,500
+125,000 vol
$5.70 each
744,285
Filed 2024-04-16 18:19
Tx date 2024-04-12
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$712,500
+125,000 vol
$5.70 each
619,285
Filed 2024-04-16 18:18
Tx date 2024-04-12
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$894,854
+156,992 vol
$5.70 each
494,285
Filed 2024-04-05 16:19
Tx date 2024-04-01
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$53,386
+10,073 vol
$5.30 each
152,212
Filed 2024-04-05 16:18
Tx date 2024-04-01
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
57 - Exercise of rights
$-81,252.65
-14,381 vol
$5.65 each
41,778
Filed 2024-04-05 16:16
Tx date 2024-04-01
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
57 - Exercise of rights
$-40,623.50
-7,190 vol
$5.65 each
20,889
Filed 2024-03-19 20:09
Tx date 2024-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$11,426
+2,156 vol
$5.30 each
142,139
Filed 2024-01-13 16:00
Tx date 2024-01-11
$ATE
Antibe Therapeutics Inc.
Khouri, Amal
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$42,800
+40,000 vol
$1.07 each
95,334
Filed 2024-01-13 15:59
Tx date 2024-01-11
$ATE
Antibe Therapeutics Inc.
Khouri, Amal
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-42,800
-40,000 vol
$1.07 each
1,666
Filed 2023-12-19 10:00
Tx date 2023-12-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$13,332
+2,564 vol
$5.20 each
139,983
Filed 2023-11-18 15:17
Tx date 2023-11-15
$ATE
Antibe Therapeutics Inc.
Khouri, Amal
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$1,733
+1,667 vol
$1.04 each
55,334
Filed 2023-11-18 15:17
Tx date 2023-11-15
$ATE
Antibe Therapeutics Inc.
Khouri, Amal
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-1,733.68
-1,667 vol
$1.04 each
41,666
Filed 2023-09-19 11:19
Tx date 2023-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$11,739
+2,656 vol
$4.42 each
137,419
Filed 2023-09-15 18:18
Tx date 2023-09-12
$ATE
Antibe Therapeutics Inc.
Khouri, Amal
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+15,000 vol
20,000
Filed 2023-06-19 14:55
Tx date 2023-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$12,742
+2,590 vol
$4.92 each
134,763
Filed 2023-06-19 13:28
Tx date 2023-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$12,737
+2,589 vol
$4.92 each
134,762
Filed 2023-06-19 13:28
Tx date 2023-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$12,737
+2,589 vol
$4.92 each
Filed 2023-04-02 23:39
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$103,469
+23,304 vol
$4.44 each
56,159
Filed 2023-04-02 23:32
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$51,734
+11,652 vol
$4.44 each
28,079
Filed 2023-04-02 23:28
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$166,655
+37,535 vol
$4.44 each
337,293
Filed 2023-03-21 21:36
Tx date 2023-03-17
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-970,000
-125,000 vol
$7.76 each
299,758
Filed 2023-03-19 22:55
Tx date 2023-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$10,664
+2,116 vol
$5.04 each
132,173
Filed 2022-12-23 15:47
Tx date 2022-12-19
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,526
+288 vol
$5.30 each
130,057
Filed 2022-12-23 15:46
Tx date 2022-12-19
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$10,365
+1,952 vol
$5.31 each
129,769
Filed 2022-12-23 13:17
Tx date 2022-12-19
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$11,894
+2,240 vol
$5.31 each
Filed 2022-12-23 13:17
Tx date 2022-12-19
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$11,894
+2,240 vol
$5.31 each
130,057
Filed 2022-12-01 22:14
Tx date 2022-11-28
$ATE
Antibe Therapeutics Inc.
Khouri, Amal
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$24,960
+52,000 vol
$0.48 each
53,667
Filed 2022-12-01 22:13
Tx date 2022-11-28
$ATE
Antibe Therapeutics Inc.
Khouri, Amal
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-24,960
-52,000 vol
$0.48 each
43,333
Filed 2022-11-19 12:49
Tx date 2022-11-15
$ATE
Antibe Therapeutics Inc.
Khouri, Amal
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$800.16
+1,667 vol
$0.48 each
1,667
Filed 2022-11-19 12:48
Tx date 2018-03-19
$ATE
Antibe Therapeutics Inc.
Khouri, Amal
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-11-19 12:48
Tx date 2022-11-15
$ATE
Antibe Therapeutics Inc.
Khouri, Amal
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-800.16
-1,667 vol
$0.48 each
95,333
Filed 2022-11-19 12:45
Tx date 2022-11-15
$ATE
Antibe Therapeutics Inc.
Khouri, Amal
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+5,000 vol
5,000
Filed 2022-11-19 12:44
Tx date 2018-03-19
$ATE
Antibe Therapeutics Inc.
Khouri, Amal
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-10-07 11:18
Tx date 2022-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$10,674
+1,896 vol
$5.63 each
127,817
Filed 2022-09-21 16:25
Tx date 2022-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$18,950
+3,366 vol
$5.63 each
Filed 2022-09-21 16:25
Tx date 2022-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$18,950
+3,366 vol
$5.63 each
129,287
Filed 2022-08-16 15:53
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,933 vol
528,231
Filed 2021-12-10 14:10
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,933 vol
Filed 2021-12-10 13:10
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,933 vol
Filed 2021-05-20 12:52
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
Filed 2021-05-20 11:16
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
Filed 2022-06-17 21:19
Tx date 2022-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$11,661
+2,234 vol
$5.22 each
125,921
Filed 2022-03-30 16:52
Tx date 2022-03-25
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-1,181,250
-135,000 vol
$8.75 each
424,758
Filed 2022-03-29 11:14
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$48,124
+9,237 vol
$5.21 each
16,427
Filed 2022-03-29 11:13
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$96,249
+18,474 vol
$5.21 each
32,855
Filed 2022-03-29 11:12
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$164,255
+31,527 vol
$5.21 each
559,758
Filed 2022-03-28 16:43
Tx date 2022-03-22
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,282
+1,700 vol
$5.46 each
123,687
Filed 2021-12-17 18:21
Tx date 2021-12-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$10,278
+1,969 vol
$5.22 each
121,987
Filed 2021-12-10 14:10
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,933 vol
528,231
Filed 2021-12-10 13:10
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,933 vol
528,231
Filed 2021-12-10 13:10
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,933 vol
Filed 2021-05-20 12:52
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
Filed 2021-05-20 12:52
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
Filed 2021-05-20 11:16
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
Filed 2021-05-20 11:16
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
Filed 2021-11-19 20:22
Tx date 2021-11-15
$ATE
Antibe Therapeutics Inc.
Khouri, Amal
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+5,000 vol
97,000
Filed 2021-09-17 17:43
Tx date 2021-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$10,535
+1,984 vol
$5.31 each
120,018
Filed 2021-06-18 19:49
Tx date 2021-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,795
+1,669 vol
$5.27 each
118,034
Filed 2021-05-24 15:27
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$81,252
+14,381 vol
$5.65 each
14,381
Filed 2021-05-24 15:25
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$40,623
+7,190 vol
$5.65 each
7,190
Filed 2021-05-20 12:57
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$81,252
+14,381 vol
$5.65 each
Filed 2021-05-20 12:54
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$40,623
+7,190 vol
$5.65 each
Filed 2021-05-20 11:19
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$81,252
+14,381 vol
$5.65 each
Filed 2021-05-20 11:18
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$40,623
+7,190 vol
$5.65 each
Filed 2021-05-20 13:06
Tx date 2014-08-25
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+85,000 vol
85,000
Filed 2021-05-20 12:57
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$81,252
+14,381 vol
$5.65 each
14,381
Filed 2021-05-20 12:56
Tx date 2014-08-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 12:54
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$40,623
+7,190 vol
$5.65 each
7,190
Filed 2021-05-20 12:53
Tx date 2014-08-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 12:52
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
528,238
Filed 2021-05-20 11:19
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$81,252
+14,381 vol
$5.65 each
14,381
Filed 2021-05-20 11:19
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$81,252
+14,381 vol
$5.65 each
Filed 2021-05-20 11:18
Tx date 2014-08-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:18
Tx date 2014-08-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:18
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$40,623
+7,190 vol
$5.65 each
7,190
Filed 2021-05-20 11:18
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$40,623
+7,190 vol
$5.65 each
Filed 2021-05-20 11:17
Tx date 2014-08-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:17
Tx date 2014-08-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:16
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
Filed 2021-05-20 11:16
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
528,238
Filed 2021-05-20 11:15
Tx date 2014-08-25
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+85,000 vol
85,000
Filed 2021-05-20 11:15
Tx date 2014-08-25
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+85,000 vol
Filed 2014-08-27 18:03
Tx date 2014-08-25
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+85,000 vol
Filed 2014-08-27 18:03
Tx date 2014-08-25
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+85,000 vol
Filed 2021-04-06 08:42
Tx date 2021-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,712
+1,669 vol
$5.22 each
116,365
Filed 2021-01-15 18:41
Tx date 2021-01-11
$ATE
Antibe Therapeutics Inc.
Khouri, Amal
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+40,000 vol
92,000
Filed 2020-12-21 18:55
Tx date 2020-12-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,467
+1,409 vol
$5.30 each
114,696
Filed 2020-12-17 18:15
Tx date 2020-12-01
$ATE
Antibe Therapeutics Inc.
Khouri, Amal
4 - Director of Issuer
Direct Ownership
Restricted Share Units
37 - Stock split or consolidation

-468,000 vol
52,000
Filed 2020-09-28 16:52
Tx date 2020-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,709
+1,442 vol
$6.04 each
113,287
Filed 2020-07-03 16:22
Tx date 2020-07-01
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+84,288 vol
503,298
Filed 2020-06-19 10:24
Tx date 2020-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,462
+1,054 vol
$7.08 each
111,845
Filed 2020-03-16 11:53
Tx date 2020-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,679
+1,437 vol
$6.04 each
110,791
Filed 2019-12-18 11:12
Tx date 2019-12-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,444
+977 vol
$7.62 each
109,354
Filed 2019-11-28 13:12
Tx date 2019-11-28
$ATE
Antibe Therapeutics Inc.
Khouri, Amal
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+160,000 vol
520,000
Filed 2019-09-18 11:37
Tx date 2019-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,675
+1,118 vol
$7.76 each
108,377
Filed 2019-07-24 15:49
Tx date 2019-07-19
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,660
+1,008 vol
$7.60 each
107,259
Filed 2019-04-24 16:28
Tx date 2019-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+173 vol
106,251
Filed 2019-04-24 16:27
Tx date 2019-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,300
+839 vol
$7.51 each
106,078
Filed 2019-01-25
Tx date 2019-01-03
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,401
+640 vol
$8.44 each
Filed 2019-01-25
Tx date 2018-12-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,401
+640 vol
$8.44 each
105,086
Filed 2019-01-25
Tx date 2019-01-03
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+153 vol
Filed 2019-01-25
Tx date 2018-12-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+153 vol
105,239
Filed 2018-10-18
Tx date 2018-09-25
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+110 vol
104,446
Filed 2018-10-18
Tx date 2018-09-25
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,301
+762 vol
$8.27 each
104,336
Filed 2018-10-05
Tx date 2018-10-03
$ATE
Antibe Therapeutics Inc.
Khouri, Amal
4 - Director of Issuer
Direct Ownership
Restricted Share Units
97 - Other

+360,000 vol
360,000
Filed 2018-10-05
Tx date 2018-03-19
$ATE
Antibe Therapeutics Inc.
Khouri, Amal
4 - Director of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2018-08-14
Tx date 2018-06-26
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,405
+674 vol
$8.02 each
103,460
Filed 2018-08-14
Tx date 2018-06-26
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+114 vol
103,574
Filed 2018-05-01
Tx date 2018-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+103 vol
102,786
Filed 2018-05-01
Tx date 2018-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,176
+774 vol
$7.98 each
102,683
Filed 2018-02-14
Tx date 2017-12-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+122 vol
101,909
Filed 2018-02-14
Tx date 2017-12-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,294
+693 vol
$7.64 each
101,787
Filed 2017-10-06
Tx date 2017-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+103 vol
101,094
Filed 2017-10-06
Tx date 2017-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,182
+709 vol
$8.72 each
100,991
Filed 2017-10-06
Tx date 2017-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+110 vol
100,282
Filed 2017-10-06
Tx date 2017-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,163
+627 vol
$9.83 each
100,172
Filed 2017-03-31
Tx date 2017-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,185
+500 vol
$10.37 each
99,457
Filed 2017-03-31
Tx date 2017-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+88 vol
99,545
Filed 2017-03-28
Tx date 2017-03-21
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+74,010 vol
419,010
Filed 2016-12-23
Tx date 2016-12-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,194
+521 vol
$9.97 each
93,957
Filed 2016-12-22
Tx date 2016-12-22
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$50,000
+5,000 vol
$10.00 each
98,436
Filed 2016-09-26
Tx date 2016-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,636
+404 vol
$9.00 each
93,436
Filed 2016-06-20
Tx date 2016-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,638
+425 vol
$8.56 each
93,032
Filed 2016-06-03
Tx date 2016-06-02
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$100,000
+12,500 vol
$8.00 each
92,607
Filed 2016-03-25
Tx date 2016-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,109
+414 vol
$7.51 each
80,107
Filed 2015-12-18
Tx date 2015-12-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,635
+486 vol
$7.48 each
79,693
Filed 2015-12-18
Tx date 2015-12-16
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+125,000 vol
345,000
Filed 2015-09-23
Tx date 2015-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,118
+413 vol
$7.55 each
79,207
Filed 2015-06-18
Tx date 2015-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,111
+442 vol
$7.04 each
78,794